We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
Cap. Flow
+$148M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$77.8M
2
TREX icon
Trex
TREX
+$39.7M
3
DOCU
DocuSign
DOCU
+$17.2M
4
AKAM icon
Akamai
AKAM
+$16.6M
5
GLD icon
SPDR Gold Trust
GLD
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 23.15%
2 Healthcare 19.33%
3 Financials 11.9%
4 Industrials 11.25%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAVA icon
226
Endava
DAVA
$162M
$14.3M 0.07%
177,430
+4,161
+2% +$395K
CHWY icon
227
Chewy
CHWY
$9.15B
$14.3M 0.07%
464,560
-72,787
-14% -$2.89M
ESGD icon
228
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$14.1M 0.06%
250,507
-13,366
-5% -$838K
RSP icon
229
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$13.9M 0.06%
109,457
+6,194
+6% +$874K
AJG icon
230
Arthur J. Gallagher & Co
AJG
$65.5B
$13.9M 0.06%
80,920
-1,304
-2% -$231K
NOC icon
231
Northrop Grumman
NOC
$82B
$13.8M 0.06%
29,320
+606
+2% +$289K
IJH icon
232
iShares Core S&P Mid-Cap ETF
IJH
$128B
$13.7M 0.06%
313,310
+99,130
+46% +$4.79M
J icon
233
Jacobs Solutions
J
$17B
$13.7M 0.06%
152,689
-4,159
-3% -$431K
IEFA icon
234
iShares Core MSCI EAFE ETF
IEFA
$196B
$13.7M 0.06%
259,974
-160,030
-38% -$9.41M
VTI icon
235
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$13.6M 0.06%
75,570
-2,888
-4% -$576K
GLOB icon
236
Globant
GLOB
$1.67B
$13.6M 0.06%
72,480
-846
-1% -$174K
EXAS
237
DELISTED
Exact Sciences
EXAS
$13.5M 0.06%
414,577
-30,863
-7% -$1.27M
EHC icon
238
Encompass Health
EHC
$12.3B
$13.4M 0.06%
296,350
-54,171
-15% -$2.71M
MDLZ icon
239
Mondelez International
MDLZ
$79.4B
$13.3M 0.06%
242,770
+3,794
+2% +$236K
CI icon
240
Cigna
CI
$73.3B
$13.3M 0.06%
47,914
+228
+0.5% +$64.2K
WFC icon
241
Wells Fargo
WFC
$269B
$13.3M 0.06%
329,657
+14,657
+5% +$630K
XYZ
242
Block Inc
XYZ
$47B
$13M 0.06%
237,057
-33,724
-12% -$2.39M
DEO icon
243
Diageo
DEO
$52.2B
$13M 0.06%
76,449
+5,368
+8% +$962K
CDW icon
244
CDW
CDW
$17.1B
$13M 0.06%
83,040
+15,686
+23% +$2.69M
T icon
245
AT&T
T
$166B
$12.9M 0.06%
839,177
+109,608
+15% +$1.99M
XLF icon
246
State Street Financial Select Sector SPDR ETF
XLF
$59.1B
$12.8M 0.06%
420,299
+19,429
+5% +$642K
VMC icon
247
Vulcan Materials
VMC
$36.3B
$12.7M 0.06%
80,230
+1,772
+2% +$288K
PM icon
248
Philip Morris
PM
$290B
$12.6M 0.06%
152,329
+10,459
+7% +$997K
FDX icon
249
FedEx
FDX
$77.3B
$12.6M 0.06%
85,018
-14,726
-15% -$3.11M
IRT icon
250
Independence Realty Trust
IRT
$3.96B
$12.6M 0.06%
753,347
-15,085
-2% -$305K

Similar funds

William Blair & Company's Q3 2022 Portfolio in Review

As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
  • William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
  • William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
  • William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
  • William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
  • William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
  • William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.

Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.